CN114931599B - A composition for inhibiting Staphylococcus aureus biofilm and its preparation method - Google Patents
A composition for inhibiting Staphylococcus aureus biofilm and its preparation method Download PDFInfo
- Publication number
- CN114931599B CN114931599B CN202210649548.3A CN202210649548A CN114931599B CN 114931599 B CN114931599 B CN 114931599B CN 202210649548 A CN202210649548 A CN 202210649548A CN 114931599 B CN114931599 B CN 114931599B
- Authority
- CN
- China
- Prior art keywords
- extract
- composition
- ethanol
- staphylococcus aureus
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 79
- 241000191967 Staphylococcus aureus Species 0.000 title claims abstract description 63
- 238000002360 preparation method Methods 0.000 title claims abstract description 60
- 230000002401 inhibitory effect Effects 0.000 title claims abstract description 38
- 239000000284 extract Substances 0.000 claims abstract description 146
- 241000205585 Aquilegia canadensis Species 0.000 claims abstract description 62
- 235000005979 Citrus limon Nutrition 0.000 claims abstract description 52
- 244000131522 Citrus pyriformis Species 0.000 claims abstract description 52
- 229930182490 saponin Natural products 0.000 claims abstract description 50
- 150000007949 saponins Chemical class 0.000 claims abstract description 50
- 239000001397 quillaja saponaria molina bark Substances 0.000 claims abstract description 49
- 229920000241 Punicalagin Polymers 0.000 claims abstract description 34
- ZJVUMAFASBFUBG-OGJBWQGYSA-N punicalagin Chemical compound C([C@H]1O[C@@H]([C@@H]2OC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)O[C@H]2[C@@H]1OC(=O)C1=CC(O)=C(O)C(O)=C11)O)OC(=O)C2=CC(O)=C(O)C(O)=C2C2=C(O)C(O)=C(OC3=O)C4=C2C(=O)OC2=C4C3=C1C(O)=C2O ZJVUMAFASBFUBG-OGJBWQGYSA-N 0.000 claims abstract description 34
- LMIBIMUSUFYFJN-RSVYENFWSA-N punicalagin Natural products O[C@@H]1O[C@@H]2COC(=O)c3cc(O)c(O)c(O)c3c4c(O)cc5OC(=O)c6c(c(O)c(O)c7OC(=O)c4c5c67)c8c(O)c(O)c(O)cc8C(=O)O[C@H]2[C@@H]9OC(=O)c%10cc(O)c(O)c(O)c%10c%11c(O)c(O)c(O)cc%11C(=O)O[C@@H]19 LMIBIMUSUFYFJN-RSVYENFWSA-N 0.000 claims abstract description 34
- ZRKSVMFLACVUIU-UHFFFAOYSA-N punicalagin isomer Natural products OC1=C(O)C(=C2C3=4)OC(=O)C=4C4=C(O)C(O)=C3OC(=O)C2=C1C1=C(O)C(O)=C(O)C=C1C(=O)OC1C2OC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(O)OC1COC(=O)C1=CC4=C(O)C(O)=C1O ZRKSVMFLACVUIU-UHFFFAOYSA-N 0.000 claims abstract description 34
- 229940045811 echinacea purpurea extract Drugs 0.000 claims abstract description 33
- 235000018597 common camellia Nutrition 0.000 claims abstract description 31
- 235000020694 echinacea extract Nutrition 0.000 claims abstract description 15
- 241001122767 Theaceae Species 0.000 claims abstract description 8
- 239000010495 camellia oil Substances 0.000 claims abstract description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 145
- 238000000605 extraction Methods 0.000 claims description 79
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 52
- 239000012141 concentrate Substances 0.000 claims description 46
- 239000000243 solution Substances 0.000 claims description 43
- 239000000843 powder Substances 0.000 claims description 34
- 239000007788 liquid Substances 0.000 claims description 29
- 102000016943 Muramidase Human genes 0.000 claims description 27
- 108010014251 Muramidase Proteins 0.000 claims description 27
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 claims description 27
- 235000014134 echinacea Nutrition 0.000 claims description 27
- 239000004325 lysozyme Substances 0.000 claims description 27
- 229960000274 lysozyme Drugs 0.000 claims description 27
- 235000010335 lysozyme Nutrition 0.000 claims description 27
- 239000006228 supernatant Substances 0.000 claims description 27
- 239000012530 fluid Substances 0.000 claims description 23
- 244000133098 Echinacea angustifolia Species 0.000 claims description 20
- 239000000706 filtrate Substances 0.000 claims description 20
- 150000004676 glycans Chemical class 0.000 claims description 17
- 238000000034 method Methods 0.000 claims description 17
- 229920001282 polysaccharide Polymers 0.000 claims description 17
- 239000005017 polysaccharide Substances 0.000 claims description 17
- 239000007864 aqueous solution Substances 0.000 claims description 16
- 238000010828 elution Methods 0.000 claims description 16
- YDDGKXBLOXEEMN-IABMMNSOSA-N chicoric acid Chemical compound O([C@@H](C(=O)O)[C@@H](OC(=O)\C=C\C=1C=C(O)C(O)=CC=1)C(O)=O)C(=O)\C=C\C1=CC=C(O)C(O)=C1 YDDGKXBLOXEEMN-IABMMNSOSA-N 0.000 claims description 14
- 239000000469 ethanolic extract Substances 0.000 claims description 14
- 238000010992 reflux Methods 0.000 claims description 14
- 239000002002 slurry Substances 0.000 claims description 14
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 12
- 239000003480 eluent Substances 0.000 claims description 12
- 238000002156 mixing Methods 0.000 claims description 12
- 239000011347 resin Substances 0.000 claims description 12
- 229920005989 resin Polymers 0.000 claims description 12
- 239000003921 oil Substances 0.000 claims description 11
- 150000008442 polyphenolic compounds Chemical class 0.000 claims description 11
- 235000013824 polyphenols Nutrition 0.000 claims description 11
- YDDGKXBLOXEEMN-UHFFFAOYSA-N Di-E-caffeoyl-meso-tartaric acid Natural products C=1C=C(O)C(O)=CC=1C=CC(=O)OC(C(O)=O)C(C(=O)O)OC(=O)C=CC1=CC=C(O)C(O)=C1 YDDGKXBLOXEEMN-UHFFFAOYSA-N 0.000 claims description 10
- 229930016920 cichoric acid Natural products 0.000 claims description 10
- YDDGKXBLOXEEMN-WOJBJXKFSA-N dicaffeoyl-L-tartaric acid Natural products O([C@@H](C(=O)O)[C@@H](OC(=O)C=CC=1C=C(O)C(O)=CC=1)C(O)=O)C(=O)C=CC1=CC=C(O)C(O)=C1 YDDGKXBLOXEEMN-WOJBJXKFSA-N 0.000 claims description 10
- 229930003935 flavonoid Natural products 0.000 claims description 8
- 150000002215 flavonoids Chemical class 0.000 claims description 8
- 235000017173 flavonoids Nutrition 0.000 claims description 8
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 claims description 7
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 claims description 7
- 240000004530 Echinacea purpurea Species 0.000 claims description 7
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 claims description 7
- 235000001368 chlorogenic acid Nutrition 0.000 claims description 7
- 229940074393 chlorogenic acid Drugs 0.000 claims description 7
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 claims description 7
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 claims description 7
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 claims description 7
- 238000001914 filtration Methods 0.000 claims description 7
- 239000012535 impurity Substances 0.000 claims description 7
- 239000003755 preservative agent Substances 0.000 claims description 7
- 230000002335 preservative effect Effects 0.000 claims description 7
- 239000012153 distilled water Substances 0.000 claims description 6
- 238000001179 sorption measurement Methods 0.000 claims description 6
- 241000209507 Camellia Species 0.000 claims description 5
- 238000001035 drying Methods 0.000 claims description 3
- 238000001556 precipitation Methods 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 239000011259 mixed solution Substances 0.000 claims description 2
- 238000007873 sieving Methods 0.000 claims 5
- 241000628997 Flos Species 0.000 claims 3
- 238000002386 leaching Methods 0.000 claims 3
- 238000010298 pulverizing process Methods 0.000 claims 2
- YDDGKXBLOXEEMN-IABMMNSOSA-L Chicoric acid Natural products C1=C(O)C(O)=CC=C1\C=C\C(=O)O[C@@H](C([O-])=O)[C@H](C([O-])=O)OC(=O)\C=C\C1=CC=C(O)C(O)=C1 YDDGKXBLOXEEMN-IABMMNSOSA-L 0.000 claims 1
- YDDGKXBLOXEEMN-PMACEKPBSA-N dicaffeoyl-D-tartaric acid Natural products O([C@H](C(=O)O)[C@H](OC(=O)C=CC=1C=C(O)C(O)=CC=1)C(O)=O)C(=O)C=CC1=CC=C(O)C(O)=C1 YDDGKXBLOXEEMN-PMACEKPBSA-N 0.000 claims 1
- 238000010438 heat treatment Methods 0.000 claims 1
- 230000001105 regulatory effect Effects 0.000 claims 1
- 240000001548 Camellia japonica Species 0.000 abstract description 26
- 230000032770 biofilm formation Effects 0.000 abstract description 9
- 239000003814 drug Substances 0.000 abstract description 6
- 239000000419 plant extract Substances 0.000 abstract description 6
- 208000015181 infectious disease Diseases 0.000 abstract description 5
- 206010059866 Drug resistance Diseases 0.000 abstract description 4
- 235000013305 food Nutrition 0.000 abstract description 4
- 231100000053 low toxicity Toxicity 0.000 abstract description 3
- 235000017709 saponins Nutrition 0.000 description 43
- 241000526900 Camellia oleifera Species 0.000 description 23
- 241000219991 Lythraceae Species 0.000 description 18
- 235000014360 Punica granatum Nutrition 0.000 description 18
- 238000012360 testing method Methods 0.000 description 17
- 235000013399 edible fruits Nutrition 0.000 description 12
- 230000015572 biosynthetic process Effects 0.000 description 9
- 235000006193 cichoric acid Nutrition 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- 230000000052 comparative effect Effects 0.000 description 8
- 239000001963 growth medium Substances 0.000 description 7
- 239000007787 solid Substances 0.000 description 7
- 241000894006 Bacteria Species 0.000 description 6
- 230000001580 bacterial effect Effects 0.000 description 6
- 230000005764 inhibitory process Effects 0.000 description 6
- 239000002609 medium Substances 0.000 description 6
- 239000004480 active ingredient Substances 0.000 description 5
- 239000003242 anti bacterial agent Substances 0.000 description 4
- 229940088710 antibiotic agent Drugs 0.000 description 4
- 239000006227 byproduct Substances 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 239000008223 sterile water Substances 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000000941 anti-staphylcoccal effect Effects 0.000 description 2
- 244000052616 bacterial pathogen Species 0.000 description 2
- 239000000022 bacteriostatic agent Substances 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 210000002421 cell wall Anatomy 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000028993 immune response Effects 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 229920001542 oligosaccharide Polymers 0.000 description 2
- 150000002482 oligosaccharides Chemical class 0.000 description 2
- 230000002688 persistence Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000005180 public health Effects 0.000 description 2
- 230000018612 quorum sensing Effects 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 2
- 150000003648 triterpenes Chemical class 0.000 description 2
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 description 1
- 102000044503 Antimicrobial Peptides Human genes 0.000 description 1
- 108700042778 Antimicrobial Peptides Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- GYHNNYVSQQEPJS-UHFFFAOYSA-N Gallium Chemical compound [Ga] GYHNNYVSQQEPJS-UHFFFAOYSA-N 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 239000006142 Luria-Bertani Agar Substances 0.000 description 1
- ZJFKKPDLNLCPNP-QMMMGPOBSA-N N-[(3s)-2-Oxotetrahydrofuran-3-Yl]hexanamide Chemical compound CCCCCC(=O)N[C@H]1CCOC1=O ZJFKKPDLNLCPNP-QMMMGPOBSA-N 0.000 description 1
- MKYBYDHXWVHEJW-UHFFFAOYSA-N N-[1-oxo-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propan-2-yl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(C(C)NC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 MKYBYDHXWVHEJW-UHFFFAOYSA-N 0.000 description 1
- ZJFKKPDLNLCPNP-UHFFFAOYSA-N N-hexanoyl-L-homoserine lactone Natural products CCCCCC(=O)NC1CCOC1=O ZJFKKPDLNLCPNP-UHFFFAOYSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003973 alkyl amines Chemical class 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000003214 anti-biofilm Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 229940088623 biologically active substance Drugs 0.000 description 1
- 235000004883 caffeic acid Nutrition 0.000 description 1
- 229940074360 caffeic acid Drugs 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000006059 cover glass Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 238000002481 ethanol extraction Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 229910052733 gallium Inorganic materials 0.000 description 1
- 125000003147 glycosyl group Chemical group 0.000 description 1
- 230000009036 growth inhibition Effects 0.000 description 1
- 125000001475 halogen functional group Chemical group 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 239000006916 nutrient agar Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000007918 pathogenicity Effects 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- -1 polyynes Chemical class 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 238000010267 two-fold dilution method Methods 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23B—PRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
- A23B2/00—Preservation of foods or foodstuffs, in general
- A23B2/70—Preservation of foods or foodstuffs, in general by treatment with chemicals
- A23B2/725—Preservation of foods or foodstuffs, in general by treatment with chemicals in the form of liquids or solids
- A23B2/729—Organic compounds; Microorganisms; Enzymes
- A23B2/733—Compounds of undetermined constitution obtained from animals or plants
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23B—PRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
- A23B2/00—Preservation of foods or foodstuffs, in general
- A23B2/70—Preservation of foods or foodstuffs, in general by treatment with chemicals
- A23B2/725—Preservation of foods or foodstuffs, in general by treatment with chemicals in the form of liquids or solids
- A23B2/729—Organic compounds; Microorganisms; Enzymes
- A23B2/771—Organic compounds containing hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/37—Extraction at elevated pressure or temperature, e.g. pressurized solvent extraction [PSE], supercritical carbon dioxide extraction or subcritical water extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/55—Liquid-liquid separation; Phase separation
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/54—Improvements relating to the production of bulk chemicals using solvents, e.g. supercritical solvents or ionic liquids
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
技术领域technical field
本发明涉及医药和食品安全领域技术,尤其是指一种抑制金黄色葡萄球菌生物被膜的组合物及其制备方法。The invention relates to the technology in the fields of medicine and food safety, in particular to a composition for inhibiting Staphylococcus aureus biofilm and a preparation method thereof.
背景技术Background technique
金黄色葡萄球菌是食品中最常见的一种革兰氏阳性致病菌,会严重危害到公共卫生和人类健康;而生物被膜的形成是金黄色葡萄球菌在不利环境条件下持久性存在的关键因素;细菌形成生物被膜后通常能够抵抗宿主的免疫反应,相比于浮游态菌,其对抗生素、抑菌剂的耐受性更高;寻找天然、高效和不易产生耐药性的抑菌物质,在抗金黄色葡萄球菌药物开发中具有广泛的应用前景;因此,针对这一现状,迫切需要开发一种抑制金黄色葡萄球菌生物被膜的组合物及其制备方法,以满足实际的需要。Staphylococcus aureus is the most common Gram-positive pathogenic bacteria in food, which can seriously endanger public health and human health; biofilm formation is the key to the persistence of Staphylococcus aureus under adverse environmental conditions Factors; Bacteria can usually resist the host's immune response after forming a biofilm. Compared with planktonic bacteria, they are more resistant to antibiotics and bacteriostatic agents; looking for natural, efficient and less resistant bacteriostatic substances , has broad application prospects in the development of anti-staphylococcus aureus drugs; therefore, in view of this situation, there is an urgent need to develop a composition and a preparation method for inhibiting staphylococcus aureus biofilm to meet actual needs.
发明内容Contents of the invention
有鉴于此,本发明针对现有技术存在之缺失,其主要目的是提供一种抑制金黄色葡萄球菌生物被膜的组合物,其通过采用本申请提供的抑制金黄色葡萄球菌生物被膜的组合物及其制备方法,提供高效、低毒、不易产生耐药性的组合物,组合物全部为植物提取物,可有效抑制金黄色葡萄球菌的生物被膜形成,从而防治金黄色葡萄球菌的感染和危害。In view of this, the present invention aims at the deficiency in the prior art, and its main purpose is to provide a composition for inhibiting Staphylococcus aureus biofilm by using the composition for inhibiting Staphylococcus aureus biofilm provided by the application and The preparation method provides a high-efficiency, low-toxicity, and non-drug-resistant composition, all of which are plant extracts, which can effectively inhibit the formation of biofilms of staphylococcus aureus, thereby preventing the infection and harm of staphylococcus aureus.
为实现上述目的,本发明采用如下之技术方案:To achieve the above object, the present invention adopts the following technical solutions:
一种抑制金黄色葡萄球菌生物被膜的组合物的制备方法,其包括以下步骤:A kind of preparation method of the composition that suppresses Staphylococcus aureus biofilm, it comprises the following steps:
S1:油茶皂素的制备:取榨油后的油茶饼粕粉碎,过50-100目筛,以提取剂按照料液比为1:10进行提取,将提取液浓缩干燥后溶于水并进行过滤;采用大孔吸附树脂对滤液洗脱,洗脱液为30%-95%的乙醇,梯度洗脱,分别收集洗脱后的液体测定后干燥浓缩得到油茶皂素;S1: Preparation of camellia oleifera saponin: crush the camellia oleifera cake after oil extraction, pass through a 50-100 mesh sieve, extract with the extractant according to the ratio of solid to liquid at 1:10, concentrate and dry the extract, dissolve it in water and carry out Filtration; eluting the filtrate with a macroporous adsorption resin, the eluent is 30%-95% ethanol, gradient elution, collecting the eluted liquid respectively, drying and concentrating to obtain camellia saponin;
S2:金银花提取物的制备:将金银花粉碎过50-100目筛得到金银花粉末,向金银花粉末加入9倍量的水,混匀后于70-80℃水中浸提120min,将浸提液过滤,将过滤液浓缩得到浓缩液;加入80%-85%的乙醇对浓缩液进行浸提6天,将浸提后的液体进行浓缩得到浆液;采用超临界CO2流体萃取工艺对浆液萃取得到金银花提取物;S2: Preparation of honeysuckle extract: crush honeysuckle through a 50-100 mesh sieve to obtain honeysuckle powder, add 9 times the amount of water to the honeysuckle powder, mix well, extract in water at 70-80°C for 120 minutes, filter the extract, Concentrate the filtrate to obtain a concentrated solution; add 80%-85% ethanol to extract the concentrated solution for 6 days, and concentrate the extracted liquid to obtain a slurry; use supercritical CO2 fluid extraction to extract the slurry to obtain honeysuckle extract thing;
S3:紫锥菊提取物的制备:将紫锥菊粉碎过50-100目筛得到紫锥菊粉末,向紫锥菊粉末中加入20%-50%的乙醇,加热回流3次,过滤并合并滤液,得乙醇提取液与滤渣两部分;滤渣加8倍量1%的溶菌酶水溶液再次提取,过滤,将溶菌酶提取液与之前乙醇提取液合并,得紫锥菊提取液,将提取液进行浓缩得到紫锥菊提取物;S3: Preparation of Echinacea extract: crush Echinacea through a 50-100 mesh sieve to obtain Echinacea powder, add 20%-50% ethanol to the Echinacea powder, heat and reflux three times, filter and combine the filtrates to obtain ethanol extract and filter residue Two parts: add 8 times the amount of 1% lysozyme aqueous solution to the filter residue to extract again, filter, combine the lysozyme extract with the previous ethanol extract to obtain the Echinacea purpurea extract, and concentrate the extract to obtain the Echinacea purpurea extract;
S4:柠檬提取物的制备:将柠檬果实粉碎过20-50目筛,于50-60℃下,加入3-3.5倍柠檬果实重量的乙醇回流浸提3-4次,制得提取液,合并提取液并于旋转蒸发仪上浓缩回收乙醇,得到柠檬提取物;S4: Preparation of lemon extract: crush lemon fruit through a 20-50 mesh sieve, add 3-3.5 times the weight of lemon fruit to reflux extraction for 3-4 times at 50-60°C to obtain an extract, and combine The extract is concentrated on a rotary evaporator to recover ethanol to obtain lemon extract;
S5:安石榴苷的制备:将石榴皮粉碎过20-50目筛,向粉碎后的石榴皮中加入水进行闪式提取,去除上清液中的多糖:将上层提取液浓缩,加入3.5倍体积70%-90%的乙醇,低温静置10小时进行沉淀,离心,过滤,收集上清液,将上清液浓缩得到安石榴苷浓缩液;S5: Preparation of punicalagin: crush the pomegranate peel through a 20-50 mesh sieve, add water to the crushed pomegranate peel for flash extraction, remove polysaccharides in the supernatant: concentrate the supernatant extract, add 3.5 times Ethanol with a volume of 70%-90%, standing at low temperature for 10 hours to precipitate, centrifuging, filtering, collecting the supernatant, and concentrating the supernatant to obtain punicalagin concentrate;
S6:组合物的制备:将上述S1中得到的油茶皂素、S2中得到的金银花提取物、S3中得到的紫锥菊提取物、S4中得到的柠檬提取物和S5中得到的安石榴苷按照比例进行混合,向混合液中加入防腐剂,调节pH至7得到组合物;该组合物按重量百分比计包括如下组分:油茶皂素60%~75%、金银花提取物10%~20%、紫锥菊提取物7%~15%、柠檬提取物5%~10%和安石榴苷3%~5%;该金银花提取物中含绿原酸50%-90%;所述紫锥菊提取物中多糖含量≥21.50%,多酚含量≥8.70%,菊苣酸含量≥5.00%;所述柠檬提取物中总黄酮含量≥80%。S6: Preparation of the composition: the tea saponin obtained in S1 above, the honeysuckle extract obtained in S2, the echinacea purpurea extract obtained in S3, the lemon extract obtained in S4, and the punicalagin obtained in S5 are in proportion mixing, adding a preservative to the mixture, and adjusting the pH to 7 to obtain a composition; the composition includes the following components by weight percentage: 60% to 75% of camellia saponin, 10% to 20% of honeysuckle extract, echinacea purpurea 7%-15% of the extract, 5%-10% of the lemon extract and 3%-5% of punicalagin; the honeysuckle extract contains 50%-90% of chlorogenic acid; the polysaccharide content in the echinacea purpurea extract is ≥ 21.50%, polyphenol content ≥ 8.70%, cichoric acid content ≥ 5.00%; total flavonoid content in the lemon extract ≥ 80%.
作为一种优选方案:所述S1中采用洗脱液进行洗脱之前,依次采用5倍树脂量的蒸馏水、浓度为10%的乙醇溶液进行洗脱除去杂质。As a preferred solution: before the eluent is used for elution in the S1, distilled water with 5 times the amount of the resin and an ethanol solution with a concentration of 10% are used for elution to remove impurities in sequence.
作为一种优选方案:所述S1中提取剂为浓度70%的丙酮,提取温度为65℃,提取时间为2h。As a preferred solution: the extractant in S1 is acetone with a concentration of 70%, the extraction temperature is 65° C., and the extraction time is 2 hours.
作为一种优选方案:所述S2中于70-80℃水中浸提两次,该超临界CO2流体萃取条件:压力为20-22mpa,流体比为5-6%,温度为45-50℃,时间为120分钟。As a preferred solution: the S2 is leached twice in 70-80°C water, the supercritical CO2 fluid extraction conditions: the pressure is 20-22mpa, the fluid ratio is 5-6%, and the temperature is 45-50°C , the time is 120 minutes.
作为一种优选方案:所述S3中向紫锥菊粉末中加入20%-50%的乙醇后采用Ca(OH)2调节pH值至10。As a preferred solution: in the S3, 20%-50% ethanol is added to the Echinacea purpurea powder, and then Ca(OH) 2 is used to adjust the pH value to 10.
作为一种优选方案:所述S3中滤渣加8倍量1%的溶菌酶水溶液再次提取的条件为:滤渣在38℃的溶菌酶水溶液中浸泡10小时。As a preferred solution: the condition for re-extracting the filter residue in S3 with 8 times the amount of 1% lysozyme aqueous solution is: soak the filter residue in 38° C. lysozyme aqueous solution for 10 hours.
作为一种优选方案:所述S5中闪式提取条件为:石榴皮粉末与水的比例为1:3;提取转速为6000rpm;提取时间为100s。As a preferred solution: the flash extraction conditions in S5 are: the ratio of pomegranate peel powder to water is 1:3; the extraction speed is 6000 rpm; the extraction time is 100 s.
作为一种优选方案:所述S6中将各组分进行混合时按重量百分比包括:油茶皂素60%~75%、金银花提取物10%~20%、紫锥菊提取物7%~15%、柠檬提取物5%~10%和安石榴苷3%~5%。As a preferred solution: when mixing the components in S6, the components include: 60%-75% camellia saponin, 10%-20% honeysuckle extract, 7%-15% echinacea extract, lemon Extract 5%-10% and punicalagin 3%-5%.
本发明与现有技术相比具有明显的优点和有益效果,具体而言,由上述技术方案可知,通过采用本申请提供的抑制金黄色葡萄球菌生物被膜的组合物及其制备方法,提供高效、低毒、不易产生耐药性的组合物,组合物全部为植物提取物,可有效抑制金黄色葡萄球菌的生物被膜形成,从而防治金黄色葡萄球菌的感染和危害;在油茶皂素的制备过程中,采用本申请的制备条件提取出来的油茶皂素纯度高,有效的除去其他杂质;金银花提取物的制备:采用醇沉与超临界CO2流体萃取联用,得率高,纯度高,能充分提取金银花的活性成分;紫锥菊提取物是采用碱性乙醇溶液及溶菌酶对紫锥菊药材进行提取而获得,有利于提高提取物中多酚及菊苣酸的含量,大大提高了所得提取物的药效;本申请中柠檬提取物的制备和安石榴苷的制备简化了提取工艺;本组合物中是以油茶皂素为主成分,油茶皂素是油茶加工副产物油茶饼粕中提取出来的,即油茶籽榨油后产生的剩余物油茶饼粕中提取出来的,属于副产物利用,成本低,原料充足;同时油茶皂素对抑制金黄色葡萄球菌生物被膜形成的效果十分显著。Compared with the prior art, the present invention has obvious advantages and beneficial effects. Specifically, it can be seen from the above-mentioned technical scheme that by adopting the composition and preparation method thereof for inhibiting Staphylococcus aureus biofilm provided by the application, providing high-efficiency, The composition is low-toxic and not easy to produce drug resistance. The composition is all plant extracts, which can effectively inhibit the biofilm formation of Staphylococcus aureus, thereby preventing the infection and harm of Staphylococcus aureus; during the preparation process of camellia saponin Among them, the camellia saponin extracted by the preparation conditions of the present application has high purity and effectively removes other impurities; the preparation of honeysuckle extract: the combination of alcohol precipitation and supercritical CO2 fluid extraction has high yield and high purity, and can Fully extract the active ingredients of honeysuckle; Echinacea purpurea extract is obtained by extracting Echinacea purpurea medicinal materials with alkaline ethanol solution and lysozyme, which is beneficial to increase the content of polyphenols and cichoric acid in the extract, and greatly improves the efficacy of the obtained extract The preparation of lemon extract and punicalagin in this application simplifies the extraction process; in this composition, camellia saponin is the main component, and camellia saponin is extracted from camellia oleifera cake, a by-product of camellia oleifera processing, that is Camellia oleifera seed is extracted from the residue of camellia oleifera cake after oil extraction, which is a by-product utilization with low cost and sufficient raw materials; at the same time, camellia saponin has a significant effect on inhibiting the formation of Staphylococcus aureus biofilm.
具体实施方式Detailed ways
实施例1Example 1
一种抑制金黄色葡萄球菌生物被膜的组合物,按重量百分比计包括如下组分:油茶皂素60%、金银花提取物15%、紫锥菊提取物15%、柠檬提取物5%和安石榴苷5%。A composition for inhibiting Staphylococcus aureus biofilm, comprising the following components by weight percentage: 60% camellia saponin, 15% honeysuckle extract, 15% echinacea extract, 5% lemon extract and 5% punicalagin %.
该金银花提取物中含绿原酸50%-90%;所述紫锥菊提取物中多糖含量≥21.50%,多酚含量≥8.70%,菊苣酸含量≥5.00%;所述柠檬提取物中总黄酮含量≥80%。The honeysuckle extract contains 50%-90% of chlorogenic acid; the polysaccharide content in the Echinacea purpurea extract ≥ 21.50%, the polyphenol content ≥ 8.70%, and the cichoric acid content ≥ 5.00%; the total flavonoid content in the lemon extract ≥80%.
一种抑制金黄色葡萄球菌生物被膜的组合物的制备方法,其包括以下步骤:A kind of preparation method of the composition that suppresses Staphylococcus aureus biofilm, it comprises the following steps:
S1:油茶皂素的制备:取榨油后的油茶饼粕粉碎,过50目筛,以提取剂按照料液比为1:10进行提取,将提取液浓缩干燥后溶于水并进行过滤;采用大孔吸附树脂对滤液洗脱,洗脱液为30%乙醇、50%乙醇、70%乙醇、90%乙醇和95%的乙醇,梯度洗脱,分别收集洗脱后的液体测定后干燥浓缩得到油茶皂素;提取剂为浓度70%的丙酮,提取温度为65℃,提取时间为2h;采用洗脱液进行洗脱之前,依次采用5倍树脂量的蒸馏水、浓度为10%的乙醇溶液进行洗脱除去杂质。S1: Preparation of camellia oleifera saponin: crush the camellia oleifera cake after oil extraction, pass through a 50-mesh sieve, extract with an extractant at a ratio of solid to liquid of 1:10, concentrate and dry the extract, dissolve it in water and filter; Use macroporous adsorption resin to elute the filtrate, the eluent is 30% ethanol, 50% ethanol, 70% ethanol, 90% ethanol and 95% ethanol, gradient elution, collect the eluted liquid respectively, dry and concentrate Camellia oleifera saponin is obtained; the extractant is acetone with a concentration of 70%, the extraction temperature is 65°C, and the extraction time is 2h; before using the eluent for elution, successively use distilled water of 5 times the amount of resin, and a concentration of 10% ethanol solution Elution is performed to remove impurities.
S2:金银花提取物的制备:将金银花粉碎过50目筛得到金银花粉末,向金银花粉末加入9倍量的水,混匀后于70℃水中浸提120min,将浸提液过滤,将过滤液浓缩得到浓缩液;加入85%的乙醇对浓缩液进行浸提6天,将浸提后的液体进行浓缩得到浆液;采用超临界CO2流体萃取工艺对浆液萃取得到金银花提取物;于70℃水中浸提两次,该超临界CO2流体萃取条件:压力为20mpa,流体比为5%,温度为45℃,时间为120分钟。S2: Preparation of honeysuckle extract: crush honeysuckle through a 50-mesh sieve to obtain honeysuckle powder, add 9 times the amount of water to the honeysuckle powder, mix well and extract in water at 70°C for 120 minutes, filter the extract, and concentrate the filtrate Obtain a concentrated solution; add 85% ethanol to extract the concentrated solution for 6 days, concentrate the extracted liquid to obtain a slurry; use a supercritical CO2 fluid extraction process to extract the slurry to obtain a honeysuckle extract; immerse in 70 ° C water Two times, the supercritical CO2 fluid extraction conditions: the pressure is 20mpa, the fluid ratio is 5%, the temperature is 45°C, and the time is 120 minutes.
金银花:采用醇沉与超临界CO2流体萃取联用,得率高,纯度高,能充分提取金银花的活性成分。Honeysuckle: The combination of alcohol precipitation and supercritical CO 2 fluid extraction has high yield and high purity, and can fully extract the active ingredients of honeysuckle.
S3:紫锥菊提取物的制备:将紫锥菊粉碎过50目筛得到紫锥菊粉末,向紫锥菊粉末中加入50%的乙醇,采用Ca(OH)2调节pH值至10,加热回流3次,过滤并合并滤液,得乙醇提取液与滤渣两部分;滤渣加8倍量1%的溶菌酶水溶液再次提取,提取的条件为:滤渣在38℃的溶菌酶水溶液中浸泡10小时;过滤,将溶菌酶提取液与之前乙醇提取液合并,得紫锥菊提取液,将提取液进行浓缩得到紫锥菊提取物;S3: Preparation of Echinacea extract: crush Echinacea through a 50-mesh sieve to obtain Echinacea powder, add 50% ethanol to the Echinacea powder, adjust the pH value to 10 with Ca(OH) 2 , heat and reflux 3 times, filter and combine the filtrates , to obtain ethanol extract and filter residue two parts; filter residue plus 8 times the amount of 1% aqueous solution of lysozyme to extract again, the extraction conditions are: filter residue soaked in 38 ℃ aqueous solution of lysozyme for 10 hours; filter, the lysozyme extract and The previous ethanol extracts were combined to obtain the Echinacea purpurea extract, and the extract was concentrated to obtain the Echinacea purpurea extract;
紫锥菊中含多糖、多酚类(包括菊苣酸、咖啡酸的衍生物)、黄酮、精油、多炔、烷基胺和生物碱;具有提高免疫力及抗菌消炎作用;多糖类可以激发身体的细胞去对抗感染;目前市场上的紫锥菊提取物的提取方法主要是简单的水浸和醇提取,致使提取效率偏低,存在某一有效成分含量偏高,而其余有效成分含量较低的缺点,从而影响了其疗效;紫锥菊提取物是采用碱性乙醇溶液及溶菌酶对紫锥菊药材进行提取而获得,有利于提高提取物中多酚及菊苣酸的含量,大大提高了所得提取物的药效;植物细胞壁的主要成分为纤维素和果胶,溶菌酶可破坏其结构,在乙醇提取后的滤渣中,加入适量的溶菌酶,可以使紫锥菊细胞的细胞壁破坏,使其中的有效成分多糖、多酚和菊苣酸进一步释放出来,提高了紫锥菊的提取率。Echinacea contains polysaccharides, polyphenols (including derivatives of cichoric acid and caffeic acid), flavonoids, essential oils, polyynes, alkylamines and alkaloids; it has the effects of improving immunity and antibacterial and anti-inflammatory effects; polysaccharides can stimulate the body's Cells to fight against infection; the extraction methods of Echinacea purpurea extracts currently on the market are mainly simple water immersion and alcohol extraction, resulting in low extraction efficiency, and the disadvantage of high content of certain active ingredients and low content of other active ingredients. Thereby affecting its curative effect; Echinacea purpurea extract is to adopt alkaline ethanol solution and lysozyme to extract Echinacea purpurea medicinal material and obtain, is conducive to improving the content of polyphenols and cichoric acid in the extract, greatly improving the efficacy of the obtained extract; The main components of plant cell walls are cellulose and pectin, and lysozyme can destroy its structure. Adding an appropriate amount of lysozyme to the filter residue after ethanol extraction can destroy the cell walls of Echinacea purpurea cells, making the active ingredients polysaccharides and polyphenols and cichoric acid are further released, improving the extraction rate of Echinacea purpurea.
S4:柠檬提取物的制备:将柠檬果实粉碎过50目筛,于50℃下,加入3倍柠檬果实重量的乙醇回流浸提3次,制得提取液,合并提取液并于旋转蒸发仪上浓缩回收乙醇,得到柠檬提取物;S4: Preparation of lemon extract: crush the lemon fruit through a 50-mesh sieve, add 3 times the weight of the lemon fruit at 50°C and add ethanol for reflux extraction for 3 times to obtain the extract, combine the extract and put it on a rotary evaporator Concentrate and recover ethanol to obtain lemon extract;
S5:安石榴苷的制备:将石榴皮粉碎过50目筛,向粉碎后的石榴皮中加入水进行闪式提取,去除上清液中的多糖:将上层提取液浓缩,加入3.5倍体积70%的乙醇,低温静置10小时进行沉淀,离心,过滤,收集上清液,将上清液浓缩得到安石榴苷浓缩液;闪式提取条件为:石榴皮粉末与水的比例为1:3;提取转速为6000rpm;提取时间为100s。S5: Preparation of punicalagin: crush the pomegranate peel through a 50-mesh sieve, add water to the crushed pomegranate peel for flash extraction, and remove polysaccharides in the supernatant: concentrate the supernatant extract, add 3.5 times the volume of 70 % ethanol, set aside at low temperature for 10 hours to precipitate, centrifuge, filter, collect the supernatant, and concentrate the supernatant to obtain the punicalagin concentrate; the flash extraction condition is: the ratio of pomegranate peel powder to water is 1:3 ; The extraction speed is 6000rpm; the extraction time is 100s.
S6:组合物的制备:将上述S1中得到的油茶皂素60%、S2中得到的金银花提取物15%、S3中得到的紫锥菊提取物15%、S4中得到的柠檬提取物5%和S5中得到的安石榴苷5%按照比例进行混合,向混合液中加入防腐剂,调节pH至7得到组合物。S6: Preparation of composition: 60% of camellia saponin obtained in S1 above, 15% of honeysuckle extract obtained in S2, 15% of Echinacea purpurea extract obtained in S3, 5% of lemon extract obtained in S4 and S5 Mix the punicalagin 5% obtained in the method according to the ratio, add a preservative to the mixed solution, and adjust the pH to 7 to obtain the composition.
实施例2Example 2
一种抑制金黄色葡萄球菌生物被膜的组合物,按重量百分比计包括如下组分:油茶皂素65%、金银花提取物17%、紫锥菊提取物10%、柠檬提取物5%和安石榴苷3%。A composition for inhibiting Staphylococcus aureus biofilm, comprising the following components by weight percentage: 65% camellia saponin, 17% honeysuckle extract, 10% echinacea extract, 5% lemon extract and punicalagin 3 %.
该金银花提取物中含绿原酸50%-90%;所述紫锥菊提取物中多糖含量≥21.50%,多酚含量≥8.70%,菊苣酸含量≥5.00%;所述柠檬提取物中总黄酮含量≥80%。The honeysuckle extract contains 50%-90% of chlorogenic acid; the polysaccharide content in the Echinacea purpurea extract ≥ 21.50%, the polyphenol content ≥ 8.70%, and the cichoric acid content ≥ 5.00%; the total flavonoid content in the lemon extract ≥80%.
一种抑制金黄色葡萄球菌生物被膜的组合物的制备方法,其包括以下步骤:A kind of preparation method of the composition that suppresses Staphylococcus aureus biofilm, it comprises the following steps:
S1:油茶皂素的制备:取榨油后的油茶饼粕粉碎,过50目筛,以提取剂按照料液比为1:10进行提取,将提取液浓缩干燥后溶于水并进行过滤;采用大孔吸附树脂对滤液洗脱,洗脱液为30%乙醇、50%乙醇、70%乙醇、90%乙醇和95%的乙醇,梯度洗脱,分别收集洗脱后的液体测定后干燥浓缩得到油茶皂素;提取剂为浓度70%的丙酮,提取温度为65℃,提取时间为2h;采用洗脱液进行洗脱之前,依次采用5倍树脂量的蒸馏水、浓度为10%的乙醇溶液进行洗脱除去杂质。S1: Preparation of camellia oleifera saponin: crush the camellia oleifera cake after oil extraction, pass through a 50-mesh sieve, extract with an extractant at a ratio of solid to liquid of 1:10, concentrate and dry the extract, dissolve it in water and filter; Use macroporous adsorption resin to elute the filtrate, the eluent is 30% ethanol, 50% ethanol, 70% ethanol, 90% ethanol and 95% ethanol, gradient elution, collect the eluted liquid respectively, dry and concentrate Camellia oleifera saponin is obtained; the extractant is acetone with a concentration of 70%, the extraction temperature is 65°C, and the extraction time is 2h; before using the eluent for elution, successively use distilled water of 5 times the amount of resin, and a concentration of 10% ethanol solution Elution is performed to remove impurities.
S2:金银花提取物的制备:将金银花粉碎过50目筛得到金银花粉末,向金银花粉末加入9倍量的水,混匀后于70℃水中浸提120min,将浸提液过滤,将过滤液浓缩得到浓缩液;加入85%的乙醇对浓缩液进行浸提6天,将浸提后的液体进行浓缩得到浆液;采用超临界CO2流体萃取工艺对浆液萃取得到金银花提取物;于70℃水中浸提两次,该超临界CO2流体萃取条件:压力为20mpa,流体比为5%,温度为45℃,时间为120分钟。S2: Preparation of honeysuckle extract: crush honeysuckle through a 50-mesh sieve to obtain honeysuckle powder, add 9 times the amount of water to the honeysuckle powder, mix well and extract in water at 70°C for 120 minutes, filter the extract, and concentrate the filtrate Obtain a concentrated solution; add 85% ethanol to extract the concentrated solution for 6 days, concentrate the extracted liquid to obtain a slurry; use a supercritical CO2 fluid extraction process to extract the slurry to obtain a honeysuckle extract; immerse in 70 ° C water Two times, the supercritical CO2 fluid extraction conditions: the pressure is 20mpa, the fluid ratio is 5%, the temperature is 45°C, and the time is 120 minutes.
S3:紫锥菊提取物的制备:将紫锥菊粉碎过50目筛得到紫锥菊粉末,向紫锥菊粉末中加入50%的乙醇,采用Ca(OH)2调节pH值至10,加热回流3次,过滤并合并滤液,得乙醇提取液与滤渣两部分;滤渣加8倍量1%的溶菌酶水溶液再次提取,提取的条件为:滤渣在38℃的溶菌酶水溶液中浸泡10小时;过滤,将溶菌酶提取液与之前乙醇提取液合并,得紫锥菊提取液,将提取液进行浓缩得到紫锥菊提取物;S3: Preparation of Echinacea extract: crush Echinacea through a 50-mesh sieve to obtain Echinacea powder, add 50% ethanol to the Echinacea powder, adjust the pH value to 10 with Ca(OH) 2 , heat and reflux 3 times, filter and combine the filtrates , to obtain ethanol extract and filter residue two parts; filter residue plus 8 times the amount of 1% aqueous solution of lysozyme to extract again, the extraction conditions are: filter residue soaked in 38 ℃ aqueous solution of lysozyme for 10 hours; filter, the lysozyme extract and The previous ethanol extracts were combined to obtain the Echinacea purpurea extract, and the extract was concentrated to obtain the Echinacea purpurea extract;
S4:柠檬提取物的制备:将柠檬果实粉碎过50目筛,于50℃下,加入3倍柠檬果实重量的乙醇回流浸提3次,制得提取液,合并提取液并于旋转蒸发仪上浓缩回收乙醇,得到柠檬提取物;S4: Preparation of lemon extract: crush the lemon fruit through a 50-mesh sieve, add 3 times the weight of the lemon fruit at 50°C and add ethanol for reflux extraction for 3 times to obtain the extract, combine the extract and put it on a rotary evaporator Concentrate and recover ethanol to obtain lemon extract;
S5:安石榴苷的制备:将石榴皮粉碎过50目筛,向粉碎后的石榴皮中加入水进行闪式提取,去除上清液中的多糖:将上层提取液浓缩,加入3.5倍体积70%的乙醇,低温静置10小时进行沉淀,离心,过滤,收集上清液,将上清液浓缩得到安石榴苷浓缩液;闪式提取条件为:石榴皮粉末与水的比例为1:3;提取转速为6000rpm;提取时间为100s。S5: Preparation of punicalagin: crush the pomegranate peel through a 50-mesh sieve, add water to the crushed pomegranate peel for flash extraction, and remove polysaccharides in the supernatant: concentrate the supernatant extract, add 3.5 times the volume of 70 % ethanol, set aside at low temperature for 10 hours to precipitate, centrifuge, filter, collect the supernatant, and concentrate the supernatant to obtain the punicalagin concentrate; the flash extraction condition is: the ratio of pomegranate peel powder to water is 1:3 ; The extraction speed is 6000rpm; the extraction time is 100s.
S6:组合物的制备:将上述S1中得到的油茶皂素65%、S2中得到的金银花提取物17%、S3中得到的紫锥菊提取物10%、S4中得到的柠檬提取物5%和S5中得到的安石榴苷3%按照比例进行混合,向混合液中加入防腐剂,调节pH至7得到组合物。S6: Preparation of composition: 65% of camellia saponin obtained in S1 above, 17% of honeysuckle extract obtained in S2, 10% of Echinacea purpurea extract obtained in S3, 5% of lemon extract obtained in S4 and S5 The 3% punicalagin obtained in the method was mixed according to the proportion, and a preservative was added to the mixed liquid, and the pH was adjusted to 7 to obtain the composition.
实施例3Example 3
一种抑制金黄色葡萄球菌生物被膜的组合物,按重量百分比计包括如下组分:油茶皂素70%、金银花提取物17%、紫锥菊提取物5%、柠檬提取物5%和安石榴苷3%A composition for inhibiting Staphylococcus aureus biofilm, comprising the following components by weight percentage: Camellia saponin 70%, honeysuckle extract 17%, Echinacea purpurea extract 5%, lemon extract 5% and punicalagin 3% %
该金银花提取物中含绿原酸50%-90%;所述紫锥菊提取物中多糖含量≥21.50%,多酚含量≥8.70%,菊苣酸含量≥5.00%;所述柠檬提取物中总黄酮含量≥80%。The honeysuckle extract contains 50%-90% of chlorogenic acid; the polysaccharide content in the Echinacea purpurea extract ≥ 21.50%, the polyphenol content ≥ 8.70%, and the cichoric acid content ≥ 5.00%; the total flavonoid content in the lemon extract ≥80%.
一种抑制金黄色葡萄球菌生物被膜的组合物的制备方法,其包括以下步骤:A kind of preparation method of the composition that suppresses Staphylococcus aureus biofilm, it comprises the following steps:
S1:油茶皂素的制备:取榨油后的油茶饼粕粉碎,过50目筛,以提取剂按照料液比为1:10进行提取,将提取液浓缩干燥后溶于水并进行过滤;采用大孔吸附树脂对滤液洗脱,洗脱液为30%乙醇、50%乙醇、70%乙醇、90%乙醇和95%的乙醇,梯度洗脱,分别收集洗脱后的液体测定后干燥浓缩得到油茶皂素;提取剂为浓度70%的丙酮,提取温度为65℃,提取时间为2h;采用洗脱液进行洗脱之前,依次采用5倍树脂量的蒸馏水、浓度为10%的乙醇溶液进行洗脱除去杂质。S1: Preparation of camellia oleifera saponin: crush the camellia oleifera cake after oil extraction, pass through a 50-mesh sieve, extract with an extractant at a ratio of solid to liquid of 1:10, concentrate and dry the extract, dissolve it in water and filter; Use macroporous adsorption resin to elute the filtrate, the eluent is 30% ethanol, 50% ethanol, 70% ethanol, 90% ethanol and 95% ethanol, gradient elution, collect the eluted liquid respectively, dry and concentrate Camellia oleifera saponin is obtained; the extractant is acetone with a concentration of 70%, the extraction temperature is 65°C, and the extraction time is 2h; before using the eluent for elution, successively use distilled water of 5 times the amount of resin, and a concentration of 10% ethanol solution Elution is performed to remove impurities.
S2:金银花提取物的制备:将金银花粉碎过50目筛得到金银花粉末,向金银花粉末加入9倍量的水,混匀后于70℃水中浸提120min,将浸提液过滤,将过滤液浓缩得到浓缩液;加入85%的乙醇对浓缩液进行浸提6天,将浸提后的液体进行浓缩得到浆液;采用超临界CO2流体萃取工艺对浆液萃取得到金银花提取物;于70℃水中浸提两次,该超临界CO2流体萃取条件:压力为20mpa,流体比为5%,温度为45℃,时间为120分钟。S2: Preparation of honeysuckle extract: crush honeysuckle through a 50-mesh sieve to obtain honeysuckle powder, add 9 times the amount of water to the honeysuckle powder, mix well and extract in water at 70°C for 120 minutes, filter the extract, and concentrate the filtrate Obtain a concentrated solution; add 85% ethanol to extract the concentrated solution for 6 days, concentrate the extracted liquid to obtain a slurry; use a supercritical CO2 fluid extraction process to extract the slurry to obtain a honeysuckle extract; immerse in 70 ° C water Mention twice, the supercritical CO 2 fluid extraction conditions: the pressure is 20mpa, the fluid ratio is 5%, the temperature is 45°C, and the time is 120 minutes.
S3:紫锥菊提取物的制备:将紫锥菊粉碎过50目筛得到紫锥菊粉末,向紫锥菊粉末中加入20%的乙醇,采用Ca(OH)2调节pH值至10,加热回流3次,过滤并合并滤液,得乙醇提取液与滤渣两部分;滤渣加8倍量1%的溶菌酶水溶液再次提取,提取的条件为:滤渣在38℃的溶菌酶水溶液中浸泡10小时;过滤,将溶菌酶提取液与之前乙醇提取液合并,得紫锥菊提取液,将提取液进行浓缩得到紫锥菊提取物;S3: Preparation of Echinacea extract: crush Echinacea through a 50-mesh sieve to obtain Echinacea powder, add 20% ethanol to the Echinacea powder, adjust the pH value to 10 with Ca(OH) 2 , heat and reflux three times, filter and combine the filtrates , to obtain ethanol extract and filter residue two parts; filter residue plus 8 times the amount of 1% aqueous solution of lysozyme to extract again, the extraction conditions are: filter residue soaked in 38 ℃ aqueous solution of lysozyme for 10 hours; filter, the lysozyme extract and The previous ethanol extracts were combined to obtain the Echinacea purpurea extract, and the extract was concentrated to obtain the Echinacea purpurea extract;
S4:柠檬提取物的制备:将柠檬果实粉碎过50目筛,于50℃下,加入3倍柠檬果实重量的乙醇回流浸提3次,制得提取液,合并提取液并于旋转蒸发仪上浓缩回收乙醇,得到柠檬提取物;S4: Preparation of lemon extract: crush the lemon fruit through a 50-mesh sieve, add 3 times the weight of the lemon fruit at 50°C and add ethanol for reflux extraction for 3 times to obtain the extract, combine the extract and put it on a rotary evaporator Concentrate and recover ethanol to obtain lemon extract;
S5:安石榴苷的制备:将石榴皮粉碎过50目筛,向粉碎后的石榴皮中加入水进行闪式提取,去除上清液中的多糖:将上层提取液浓缩,加入3.5倍体积70%的乙醇,低温静置10小时进行沉淀,离心,过滤,收集上清液,将上清液浓缩得到安石榴苷浓缩液;闪式提取条件为:石榴皮粉末与水的比例为1:3;提取转速为6000rpm;提取时间为100s。S5: Preparation of punicalagin: crush the pomegranate peel through a 50-mesh sieve, add water to the crushed pomegranate peel for flash extraction, and remove polysaccharides in the supernatant: concentrate the supernatant extract, add 3.5 times the volume of 70 % ethanol, set aside at low temperature for 10 hours to precipitate, centrifuge, filter, collect the supernatant, and concentrate the supernatant to obtain the punicalagin concentrate; the flash extraction condition is: the ratio of pomegranate peel powder to water is 1:3 ; The extraction speed is 6000rpm; the extraction time is 100s.
S6:组合物的制备:将上述S1中得到的油茶皂素70%、S2中得到的金银花提取物17%、S3中得到的紫锥菊提取物5%、S4中得到的柠檬提取物5%和S5中得到的安石榴苷3%按照比例进行混合,向混合液中加入防腐剂,调节pH至7得到组合物。S6: Preparation of composition: 70% of Camellia saponin obtained in S1 above, 17% of honeysuckle extract obtained in S2, 5% of Echinacea purpurea extract obtained in S3, 5% of lemon extract obtained in S4 and S5 The 3% punicalagin obtained in the method was mixed according to the proportion, and a preservative was added to the mixed liquid, and the pH was adjusted to 7 to obtain the composition.
实施例4Example 4
一种抑制金黄色葡萄球菌生物被膜的组合物,按重量百分比计包括如下组分:油茶皂素75%、金银花提取物10%、紫锥菊提取物7%、柠檬提取物5%和安石榴苷3%。A composition for inhibiting Staphylococcus aureus biofilm, comprising the following components by weight percentage: 75% camellia saponin, 10% honeysuckle extract, 7% echinacea extract, 5% lemon extract and punicalagin 3 %.
该金银花提取物中含绿原酸50%-90%;所述紫锥菊提取物中多糖含量≥21.50%,多酚含量≥8.70%,菊苣酸含量≥5.00%;所述柠檬提取物中总黄酮含量≥80%。The honeysuckle extract contains 50%-90% of chlorogenic acid; the polysaccharide content in the Echinacea purpurea extract ≥ 21.50%, the polyphenol content ≥ 8.70%, and the cichoric acid content ≥ 5.00%; the total flavonoid content in the lemon extract ≥80%.
一种抑制金黄色葡萄球菌生物被膜的组合物的制备方法,其包括以下步骤:A kind of preparation method of the composition that suppresses Staphylococcus aureus biofilm, it comprises the following steps:
S1:油茶皂素的制备:取榨油后的油茶饼粕粉碎,过50目筛,以提取剂按照料液比为1:10进行提取,将提取液浓缩干燥后溶于水并进行过滤;采用大孔吸附树脂对滤液洗脱,洗脱液为30%乙醇、50%乙醇、70%乙醇、90%乙醇和95%的乙醇,梯度洗脱,分别收集洗脱后的液体测定后干燥浓缩得到油茶皂素;提取剂为浓度70%的丙酮,提取温度为65℃,提取时间为2h;采用洗脱液进行洗脱之前,依次采用5倍树脂量的蒸馏水、浓度为10%的乙醇溶液进行洗脱除去杂质。S1: Preparation of camellia oleifera saponin: crush the camellia oleifera cake after oil extraction, pass through a 50-mesh sieve, extract with an extractant at a ratio of solid to liquid of 1:10, concentrate and dry the extract, dissolve it in water and filter; Use macroporous adsorption resin to elute the filtrate, the eluent is 30% ethanol, 50% ethanol, 70% ethanol, 90% ethanol and 95% ethanol, gradient elution, collect the eluted liquid respectively, dry and concentrate Camellia oleifera saponin is obtained; the extractant is acetone with a concentration of 70%, the extraction temperature is 65°C, and the extraction time is 2h; before using the eluent for elution, successively use distilled water of 5 times the amount of resin, and a concentration of 10% ethanol solution Elution is performed to remove impurities.
S2:金银花提取物的制备:将金银花粉碎过50目筛得到金银花粉末,向金银花粉末加入9倍量的水,混匀后于70℃水中浸提120min,将浸提液过滤,将过滤液浓缩得到浓缩液;加入85%的乙醇对浓缩液进行浸提6天,将浸提后的液体进行浓缩得到浆液;采用超临界CO2流体萃取工艺对浆液萃取得到金银花提取物;于70℃水中浸提两次,该超临界CO2流体萃取条件:压力为20mpa,流体比为5%,温度为45℃,时间为120分钟。S2: Preparation of honeysuckle extract: crush honeysuckle through a 50-mesh sieve to obtain honeysuckle powder, add 9 times the amount of water to the honeysuckle powder, mix well and extract in water at 70°C for 120 minutes, filter the extract, and concentrate the filtrate Obtain a concentrated solution; add 85% ethanol to extract the concentrated solution for 6 days, concentrate the extracted liquid to obtain a slurry; use a supercritical CO2 fluid extraction process to extract the slurry to obtain a honeysuckle extract; immerse in 70 ° C water Mention twice, the supercritical CO 2 fluid extraction conditions: the pressure is 20mpa, the fluid ratio is 5%, the temperature is 45°C, and the time is 120 minutes.
S3:紫锥菊提取物的制备:将紫锥菊粉碎过50目筛得到紫锥菊粉末,向紫锥菊粉末中加入20%%的乙醇,采用Ca(OH)2调节pH值至10,加热回流3次,过滤并合并滤液,得乙醇提取液与滤渣两部分;滤渣加8倍量1%的溶菌酶水溶液再次提取,提取的条件为:滤渣在38℃的溶菌酶水溶液中浸泡10小时;过滤,将溶菌酶提取液与之前乙醇提取液合并,得紫锥菊提取液,将提取液进行浓缩得到紫锥菊提取物;S3: Preparation of Echinacea extract: crush Echinacea through a 50-mesh sieve to obtain Echinacea powder, add 20%% ethanol to the Echinacea powder, adjust the pH value to 10 with Ca(OH) 2 , heat and reflux 3 times, filter and combine Filtrate, to obtain two parts of ethanol extract and filter residue; add 8 times the amount of 1% lysozyme aqueous solution to the filter residue to extract again, the extraction conditions are: soak the filter residue in 38 ℃ lysozyme aqueous solution for 10 hours; filter, and lysozyme extract Combine with the previous ethanol extract to obtain the Echinacea purpurea extract, and concentrate the extract to obtain the Echinacea purpurea extract;
S4:柠檬提取物的制备:将柠檬果实粉碎过50目筛,于50℃下,加入3倍柠檬果实重量的乙醇回流浸提3次,制得提取液,合并提取液并于旋转蒸发仪上浓缩回收乙醇,得到柠檬提取物;S4: Preparation of lemon extract: crush the lemon fruit through a 50-mesh sieve, add 3 times the weight of the lemon fruit at 50°C and add ethanol for reflux extraction for 3 times to obtain the extract, combine the extract and put it on a rotary evaporator Concentrate and recover ethanol to obtain lemon extract;
S5:安石榴苷的制备:将石榴皮粉碎过50目筛,向粉碎后的石榴皮中加入水进行闪式提取,去除上清液中的多糖:将上层提取液浓缩,加入3.5倍体积70%的乙醇,低温静置10小时进行沉淀,离心,过滤,收集上清液,将上清液浓缩得到安石榴苷浓缩液;闪式提取条件为:石榴皮粉末与水的比例为1:3;提取转速为6000rpm;提取时间为100s。S5: Preparation of punicalagin: crush the pomegranate peel through a 50-mesh sieve, add water to the crushed pomegranate peel for flash extraction, and remove polysaccharides in the supernatant: concentrate the supernatant extract, add 3.5 times the volume of 70 % ethanol, set aside at low temperature for 10 hours to precipitate, centrifuge, filter, collect the supernatant, and concentrate the supernatant to obtain the punicalagin concentrate; the flash extraction condition is: the ratio of pomegranate peel powder to water is 1:3 ; The extraction speed is 6000rpm; the extraction time is 100s.
S6:组合物的制备:将上述S1中得到的油茶皂素75%、S2中得到的金银花提取物10%、S3中得到的紫锥菊提取物7%、S4中得到的柠檬提取物5%和S5中得到的安石榴苷3%按照比例进行混合,向混合液中加入防腐剂,调节pH至7得到组合物。S6: Preparation of composition: 75% of camellia saponin obtained in S1 above, 10% of honeysuckle extract obtained in S2, 7% of Echinacea purpurea extract obtained in S3, 5% of lemon extract obtained in S4 and S5 The 3% punicalagin obtained in the method was mixed according to the proportion, and a preservative was added to the mixed liquid, and the pH was adjusted to 7 to obtain the composition.
对比例1Comparative example 1
一种抑制金黄色葡萄球菌生物被膜的组合物,按重量百分比计包括如下组分:金银花提取物15%、紫锥菊提取物15%、柠檬提取物5%和安石榴苷5%。A composition for inhibiting Staphylococcus aureus biofilm, comprising the following components by weight percentage: 15% of honeysuckle extract, 15% of Echinacea purpurea extract, 5% of lemon extract and 5% of punicalagin.
该金银花提取物中含绿原酸50%-90%;所述紫锥菊提取物中多糖含量≥21.50%,多酚含量≥8.70%,菊苣酸含量≥5.00%;所述柠檬提取物中总黄酮含量≥80%。The honeysuckle extract contains 50%-90% of chlorogenic acid; the polysaccharide content in the Echinacea purpurea extract ≥ 21.50%, the polyphenol content ≥ 8.70%, and the cichoric acid content ≥ 5.00%; the total flavonoid content in the lemon extract ≥80%.
一种抑制金黄色葡萄球菌生物被膜的组合物的制备方法,其包括以下步骤:A kind of preparation method of the composition that suppresses Staphylococcus aureus biofilm, it comprises the following steps:
S1:金银花提取物的制备:将金银花粉碎过50目筛得到金银花粉末,向金银花粉末加入9倍量的水,混匀后于70℃水中浸提120min,将浸提液过滤,将过滤液浓缩得到浓缩液;加入85%的乙醇对浓缩液进行浸提6天,将浸提后的液体进行浓缩得到浆液;采用超临界CO2流体萃取工艺对浆液萃取得到金银花提取物;于70℃水中浸提两次,该超临界CO2流体萃取条件:压力为20mpa,流体比为5%,温度为45℃,时间为120分钟。S1: Preparation of honeysuckle extract: crush honeysuckle through a 50-mesh sieve to obtain honeysuckle powder, add 9 times the amount of water to the honeysuckle powder, mix well and extract in water at 70°C for 120 minutes, filter the extract, and concentrate the filtrate Obtain a concentrated solution; add 85% ethanol to extract the concentrated solution for 6 days, concentrate the extracted liquid to obtain a slurry; use a supercritical CO2 fluid extraction process to extract the slurry to obtain a honeysuckle extract; immerse in 70 ° C water Mention twice, the supercritical CO 2 fluid extraction conditions: the pressure is 20mpa, the fluid ratio is 5%, the temperature is 45°C, and the time is 120 minutes.
S2:紫锥菊提取物的制备:将紫锥菊粉碎过50目筛得到紫锥菊粉末,向紫锥菊粉末中加入50%的乙醇,采用Ca(OH)2调节pH值至10,加热回流3次,过滤并合并滤液,得乙醇提取液与滤渣两部分;滤渣加8倍量1%的溶菌酶水溶液再次提取,提取的条件为:滤渣在38℃的溶菌酶水溶液中浸泡10小时;过滤,将溶菌酶提取液与之前乙醇提取液合并,得紫锥菊提取液,将提取液进行浓缩得到紫锥菊提取物;S2: Preparation of Echinacea extract: crush Echinacea through a 50-mesh sieve to obtain Echinacea powder, add 50% ethanol to the Echinacea powder, adjust the pH value to 10 with Ca(OH) 2 , heat and reflux 3 times, filter and combine the filtrates , to obtain ethanol extract and filter residue two parts; filter residue plus 8 times the amount of 1% aqueous solution of lysozyme to extract again, the extraction conditions are: filter residue soaked in 38 ℃ aqueous solution of lysozyme for 10 hours; filter, the lysozyme extract and The previous ethanol extracts were combined to obtain the Echinacea purpurea extract, and the extract was concentrated to obtain the Echinacea purpurea extract;
S3:柠檬提取物的制备:将柠檬果实粉碎过50目筛,于50℃下,加入3倍柠檬果实重量的乙醇回流浸提3次,制得提取液,合并提取液并于旋转蒸发仪上浓缩回收乙醇,得到柠檬提取物;S3: Preparation of lemon extract: crush lemon fruit through a 50-mesh sieve, add ethanol 3 times the weight of lemon fruit at 50°C for reflux extraction for 3 times to obtain an extract, combine the extracts and put them on a rotary evaporator Concentrate and recover ethanol to obtain lemon extract;
S4:安石榴苷的制备:将石榴皮粉碎过50目筛,向粉碎后的石榴皮中加入水进行闪式提取,去除上清液中的多糖:将上层提取液浓缩,加入3.5倍体积70%的乙醇,低温静置10小时进行沉淀,离心,过滤,收集上清液,将上清液浓缩得到安石榴苷浓缩液;闪式提取条件为:石榴皮粉末与水的比例为1:3;提取转速为6000rpm;提取时间为100s。S4: Preparation of punicalagin: crush the pomegranate peel through a 50-mesh sieve, add water to the crushed pomegranate peel for flash extraction, and remove polysaccharides in the supernatant: concentrate the supernatant extract, add 3.5 times the volume of 70 % ethanol, set aside at low temperature for 10 hours to precipitate, centrifuge, filter, collect the supernatant, and concentrate the supernatant to obtain the punicalagin concentrate; the flash extraction condition is: the ratio of pomegranate peel powder to water is 1:3 ; The extraction speed is 6000rpm; the extraction time is 100s.
S5:组合物的制备:将上述S1中得到的金银花提取物15%、S2中得到的紫锥菊提取物15%、S3中得到的柠檬提取物5%和S4中得到的安石榴苷5%按照比例进行混合,向混合液中加入防腐剂,调节pH至7得到组合物。S5: Preparation of the composition: 15% of the honeysuckle extract obtained in the above S1, 15% of the Echinacea purpurea extract obtained in S2, 5% of the lemon extract obtained in S3 and 5% of punicalagin obtained in S4 according to the proportion Mixing is carried out, a preservative is added to the mixture, and the pH is adjusted to 7 to obtain a composition.
效果实施例1Effect Example 1
组合物对金黄色葡萄球菌最小抑菌浓度(MIC)测定:Composition is measured to Staphylococcus aureus minimum inhibitory concentration (MIC):
取等量实施例1和实施例4制备所得的组合物,分别用无菌水溶解,将实施例1和实施例4制备所得的组合物均配制成质量浓度为4mg/mL、8mg/mL、16mg/mL、32mg/mL和64mg/mL的油茶皂素溶液,于4℃冰箱保存备用;制备金黄色葡萄球菌菌种活化:配置营养琼脂培养基(NA)1L,121℃高温灭菌20min后取出,倒入灭菌后的培养皿,冷却后获得固体培养基,从-8℃冰箱取菌株,用接种环挑取细菌在固体培养基上划线,放置在恒温培养箱中培养18h,培养温度37℃;菌悬液的制备:用接种环挑取单菌落接种到液体培养基中,37℃下150r/min恒温摇床培养14h;再以1%接种量接种至10mL的无菌水中,依次稀释,通过比浊法,使菌落数为106cfu/mL;最小抑菌浓度(MIC)测定:采用二倍稀释法,取两组无菌试管,每组为6根无菌试管,进行编号,然后向每管试管中加入2mL培养基,在第一组无菌试管中:第一管中加入2mL实施例1制备的组合物溶液,混匀后取2mL加入第二根试管中,依次稀释,最后一根试管混匀后,取2mL液体弃掉;在第二组无菌试管中:第一管中加入2mL实施例4制备的组合物溶液,混匀后取2mL加入第二根试管中,依次稀释,最后一根试管混匀后,取2mL液体弃掉;分别向上述试管中接入100μL的106cfu/mL菌悬液,放置恒温培养箱37℃培养24-48h,观察试管中液体是否变浑浊,重复上述实验3次;试管中液体浑浊程度见表1;Get equal amounts of the compositions prepared in Example 1 and Example 4 and dissolve them in sterile water respectively. 16mg/mL, 32mg/mL and 64mg/mL Camellia saponin solutions were stored in a 4°C refrigerator for later use; preparation of Staphylococcus aureus strain activation: prepare 1 L of nutrient agar medium (NA), and sterilize at 121°C for 20 minutes Take it out, pour it into a sterilized petri dish, and obtain a solid medium after cooling. Take the strain from the -8°C refrigerator, pick up the bacteria with an inoculation loop, mark the line on the solid medium, and place it in a constant temperature incubator for 18 hours. The temperature is 37°C; the preparation of the bacterial suspension: use an inoculation loop to pick a single colony and inoculate it into the liquid medium, and cultivate it on a constant temperature shaker at 150r/min at 37°C for 14 hours; then inoculate 1% of the inoculum into 10mL of sterile water, Sequentially dilute, by turbidimetric method, the number of colonies is 106cfu/mL; minimum inhibitory concentration (MIC) measurement: adopt two-fold dilution method, get two groups of sterile test tubes, each group is 6 sterile test tubes, carry out numbering, Then add 2mL of culture medium to each test tube, in the first group of sterile test tubes: add 2mL of the composition solution prepared in Example 1 to the first tube, take 2mL after mixing and add it to the second test tube, and dilute in turn, After mixing the last test tube, take 2mL of liquid and discard it; in the second group of sterile test tubes: add 2mL of the composition solution prepared in Example 4 to the first tube, take 2mL and add it to the second test tube after mixing, Dilute sequentially. After the last test tube is mixed, take 2 mL of liquid and discard it; add 100 μL of 106 cfu/mL bacterial suspension to the above test tubes respectively, place in a constant temperature incubator at 37 ° C for 24-48 hours, and observe whether the liquid in the test tube changes. Turbidity, repeat the above experiment 3 times; see Table 1 for the degree of turbidity of the liquid in the test tube;
表1:两组试管中液体浑浊程度:Table 1: The degree of turbidity of the liquid in the two groups of test tubes:
试验结果分析:Analysis of test results:
由表1可知,当实施例1中茶油皂素浓度为32mg/mL时,溶液开始浑浊,则实施例1中茶油皂素MIC为64mg/mL;当实施例4中茶油皂素浓度为16mg/mL时,溶液开始浑浊,则实施例4中茶油皂素的MIC为32mg/mL。As can be seen from Table 1, when the concentration of camellia saponin in Example 1 was 32mg/mL, the solution began to be turbid, and the MIC of camellia saponin in Example 1 was 64mg/mL; when the concentration of camellia saponin in Example 4 When it was 16mg/mL, the solution began to be turbid, and the MIC of camellia saponin in Example 4 was 32mg/mL.
效果实施例2Effect Example 2
组合物对金黄色葡萄球菌群体感应抑制作用试验:Composition to staphylococcus aureus quorum sensing inhibition test:
接金黄色葡萄球菌过夜培养,调培养液OD值为0.1;取200μL菌液加入到100mL融化LB琼脂培养基(50℃)中,同时加入200μL信号分子C6-HSL(终浓度为5μM)和卡那霉素(终浓度20μg/mL);混匀后均匀地倒在6个平板上;待平板冷凝后,放置无菌牛津杯;将等量的实施例1-实施例4制备的组合物、对比例1制备的组合物和对照组(无菌水)加入到牛津杯中,室温孵育1h,然后再28℃过夜培养;基于在孔周围形成无色但有活细胞生长的光圈来评估群体感应抑制作用,用卡尺测定各处理菌落直径,单位为mm;用十字交叉法垂直测定直径各次,取平均值;按照下式计算菌丝生长抑制率。Inoculate Staphylococcus aureus for overnight culture, and adjust the OD value of the culture medium to 0.1; take 200 μL of the bacterial solution and add it to 100 mL of melted LB agar medium (50 °C), and add 200 μL of the signal molecule C6-HSL (final concentration: 5 μM) and Ca Namycin (final concentration 20 μg/mL); evenly poured on 6 plates after mixing; after the plates condensed, place a sterile Oxford cup; The composition prepared in Comparative Example 1 and the control group (sterile water) were added to an Oxford cup, incubated at room temperature for 1 hour, and then cultured overnight at 28°C; quorum sensing was assessed based on the formation of a colorless halo around the well with viable cell growth Inhibition, use a caliper to measure the colony diameter of each treatment, and the unit is mm; use the cross method to measure the diameter vertically each time, and take the average value; calculate the mycelial growth inhibition rate according to the following formula.
菌丝抑制率(%)=(对照菌落增长直径-处理菌落增长直径)/对照菌落增长直径*100Mycelium inhibition rate (%)=(control colony growth diameter-treatment colony growth diameter)/control colony growth diameter*100
组合物对金黄色葡萄球菌抑制效果见表2:Composition is shown in Table 2 to Staphylococcus aureus inhibitory effect:
表2:实施例1-4、对比例1和对照组制备的组合物对金黄色葡萄球菌的抑制效果Table 2: The inhibitory effect of the compositions prepared by Examples 1-4, Comparative Example 1 and the control group on Staphylococcus aureus
表2结果表明,实施例1-4制备的组合物对金黄色葡萄球菌具有较高的抑制活性,实施1到实施例4随着油茶皂素质量占比的增加,对于金黄色葡萄球菌的抑制效果更好;当油茶皂素75%、金银花提取物10%、紫锥菊提取物7%、柠檬提取物5%和安石榴苷3%制备的组合物对于金黄色葡萄球菌的抑制效果最佳;由对比例1可以看出不添加油茶皂素时其抑菌效果较差,说明在制备得到的组合物中油茶皂素在抑制金黄色葡萄球菌方面起到主要效果。The results in Table 2 show that the compositions prepared in Examples 1-4 have higher inhibitory activity to Staphylococcus aureus, and the implementation of Examples 1 to 4 increases the proportion of camellia saponin for the inhibition of Staphylococcus aureus. The effect is better; the composition prepared when Camellia saponin 75%, honeysuckle extract 10%, Echinacea purpurea extract 7%, lemon extract 5% and punicalagin 3% has the best inhibitory effect on Staphylococcus aureus; by It can be seen from Comparative Example 1 that the bacteriostasis effect is poor when no camellia saponin is added, indicating that camellia saponin plays a major role in inhibiting Staphylococcus aureus in the prepared composition.
效果实施例3Effect Example 3
组合物对金黄色葡萄球菌生物被膜形成的抑制作用试验:The inhibitory action test of composition to Staphylococcus aureus biofilm formation:
接种金黄色葡萄球菌单菌落至5mL NB液体培养基,于温度为28℃,180rpm培养24h,将上述菌液在600nm波长处的吸光值调至0.06-0.10;取菌液10μL加至5mL NB培养基中,该培养基分为6组,每组为10个培养基,于其中5组培养基中分别加入实施例1-4和对比例1制备的组合物,于另外一组培养基中加入无菌水作为空白对照试验;于该6组培养基中分别取1mL混合后的菌液,加至6组底部放有圆形盖玻片的平底孔板中,28℃下静置培养24h;培养后,取出6组底层的圆形盖玻片,PBS洗去浮游的细菌;该6组盖玻片上的被膜均用2.5%的戊二醛固定12h,然后依次用50%乙醇、70%乙醇、80%乙醇、90%乙醇和100%乙醇进行梯度脱水(每个浓度洗脱10min),冷冻干燥机进行冷冻干燥后在酶标仪上读取OD570值,每个样品重复三次后取平均吸收值;该吸收值在一定范围内与被膜的产量成正比关系,并应用如下公式计算实施例1-4和对比例1制备所得的样品对金黄色葡萄球菌生物被膜形成的抑制率:Inoculate a single colony of Staphylococcus aureus into 5mL NB liquid medium, culture at 28°C and 180rpm for 24 hours, adjust the absorbance of the above bacterial solution at 600nm wavelength to 0.06-0.10; take 10μL of the bacterial solution and add it to 5mL NB culture In the base, the culture medium is divided into 6 groups, each group is 10 culture media, the composition prepared in Example 1-4 and Comparative Example 1 is added respectively to 5 groups of culture media among them, and the composition prepared in another group of culture media is added Sterile water was used as a blank control test; 1 mL of the mixed bacterial solution was taken from the culture medium of the 6 groups, and added to the flat-bottomed well plate with a round cover glass at the bottom of the 6 groups, and cultured at 28°C for 24 hours; After culturing, take out the circular coverslips at the bottom of the 6 groups, and wash away the planktonic bacteria with PBS; the capsules on the 6 groups of coverslips are all fixed with 2.5% glutaraldehyde for 12 hours, and then washed with 50% ethanol and 70% ethanol in turn. , 80% ethanol, 90% ethanol and 100% ethanol for gradient dehydration (each concentration eluted for 10min), freeze-dried in a freeze dryer and read the OD570 value on a microplate reader, and each sample was repeated three times to get the average absorption value; this absorption value is directly proportional to the output of film within a certain range, and the sample prepared by using the following formula to calculate embodiment 1-4 and comparative example 1 is to the inhibitory rate of Staphylococcus aureus biofilm formation:
抑制率=(阴性对照A570均值-样品A570均值)/阴性对照A570均值×100%Inhibition rate = (negative control A570 average - sample A570 average) / negative control A570 average × 100%
组合物对金黄色葡萄球菌生物被膜形成的抑制效果见表3;The inhibitory effect of the composition on Staphylococcus aureus biofilm formation is shown in Table 3;
表3:组合物对金黄色葡萄球菌生物被膜形成的抑制效果Table 3: Inhibitory effect of the composition on Staphylococcus aureus biofilm formation
结果分析:Result analysis:
由表3可知对照组对于金黄色葡萄球菌生物被膜形成的抑制效果较差,实施例1-4制备所得组合物对于金黄色葡萄球菌生物被膜的形成有显著抑制效果,对比例1中制备所得组合物对于金黄色葡萄球菌生物被膜的形成有一定抑制效果,实施例1-4中随着茶油皂素质量浓度的增加,对于金黄色葡萄球菌生物被膜的形成抑制效果更佳,呈现出剂量依赖性。It can be seen from Table 3 that the inhibitory effect of the control group on the formation of Staphylococcus aureus biofilm is relatively poor, and the resulting composition prepared in Examples 1-4 has a significant inhibitory effect on the formation of Staphylococcus aureus biofilm, and the resulting combination prepared in Comparative Example 1 The substance has a certain inhibitory effect on the formation of Staphylococcus aureus biofilm, and along with the increase of tea oil saponin mass concentration in embodiment 1-4, better for the formation inhibitory effect of Staphylococcus aureus biofilm, presents dose-dependent sex.
综上所述;金黄色葡萄球菌是食品中最常见的一种革兰氏阳性致病菌,会严重危害到公共卫生和人类健康;而生物被膜的形成是金黄色葡萄球菌在不利环境条件下持久性存在的关键因素;细菌形成生物被膜后通常能够抵抗宿主的免疫反应,相比于浮游态菌,其对抗生素、抑菌剂的耐受性更高;因此,寻找天然、高效和不易产生耐药性的抑菌物质,在抗金黄色葡萄球菌药物开发中具有广泛的应用前景。In summary; Staphylococcus aureus is the most common Gram-positive pathogenic bacteria in food, which will seriously endanger public health and human health; and the formation of biofilm is the main cause of Staphylococcus aureus under unfavorable environmental conditions. The key factor for persistence; bacteria can usually resist the host’s immune response after forming a biofilm, and they are more resistant to antibiotics and bacteriostats than planktonic bacteria; Drug-resistant antibacterial substances have broad application prospects in the development of anti-Staphylococcus aureus drugs.
油茶饼粕中提取得到的天然产物-油茶皂素,是齐墩果烷型五环三萜与低聚糖连接而成的一类生物活性物质,由皂苷元(糖苷配基,通常是三萜)、糖基(低聚糖)和有机酸组成;油茶皂素具有较强的发泡、乳化、分散、湿润等作用,以及抑菌、消炎、镇痛、抗癌等生理活性。Camellia oleifera saponin, a natural product extracted from camellia oleifera cake, is a type of biologically active substance formed by linking oleanane-type pentacyclic triterpenes and oligosaccharides. It consists of saponins (aglycones, usually triterpene ), glycosyl (oligosaccharides) and organic acids; camellia saponin has strong foaming, emulsifying, dispersing, moisturizing effects, as well as antibacterial, anti-inflammatory, analgesic, anti-cancer and other physiological activities.
金黄色葡萄球菌的生物被膜是其致病性强和耐药性强的关键因素;目前用于防治金黄色葡萄球菌生物被膜的方法主要是采用新型抗生素、新型抗生物被膜药剂(酶、镓基疗法等)、植物提取物、抗菌肽,与抗生素类药物联用等。The biofilm of Staphylococcus aureus is the key factor of its strong pathogenicity and strong drug resistance; the method currently used to prevent and treat the biofilm of Staphylococcus aureus mainly adopts new antibiotics and new anti-biofilm agents (enzyme, gallium-based therapy, etc.), plant extracts, antimicrobial peptides, combined with antibiotics, etc.
本发明的设计重点在于提供高效、低毒、不易产生耐药性的组合物,组合物全部为植物提取物,可有效抑制金黄色葡萄球菌的生物被膜形成,从而防治金黄色葡萄球菌的感染和危害。The focus of the design of the present invention is to provide a composition with high efficiency, low toxicity, and not easy to produce drug resistance. The composition is all plant extracts, which can effectively inhibit the biofilm formation of Staphylococcus aureus, thereby preventing and treating the infection and disease of Staphylococcus aureus. harm.
本发明的优点还体现在用于抑制金黄色葡萄球菌生物被膜的植物提取物相对成本较高,但本组合物中是以油茶皂素为主成分,油茶皂素是油茶加工副产物油茶饼粕中提取出来的,即油茶籽榨油后产生的剩余物油茶饼粕中提取出来的,属于副产物利用,成本低,原料充足;同时油茶皂素对抑制金黄色葡萄球菌生物被膜形成的效果十分显著。The advantages of the present invention are also reflected in the relatively high cost of the plant extracts used to inhibit the biofilm of Staphylococcus aureus, but in this composition, camellia saponin is the main component, and camellia saponin is a by-product of camellia oleifera processing. Camellia oleifera saponin, which is the residue of camellia oleifera cake after oil-pressing, belongs to by-product utilization, low cost, and sufficient raw materials; at the same time, camellia saponin has a very good effect on inhibiting the formation of Staphylococcus aureus biofilm significantly.
以上所述,仅是本发明的较佳实施例而已,并非对本发明的技术范围作任何限制,故凡是依据本发明的技术实质对以上实施例所做的任何细微修改、等同变化与修饰,均仍属于本发明技术方案的范围内。The above descriptions are only preferred embodiments of the present invention, and do not limit the technical scope of the present invention in any way, so any minor modifications, equivalent changes and modifications made to the above embodiments according to the technical essence of the present invention are valid. Still belong to the scope of the technical solution of the present invention.
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210649548.3A CN114931599B (en) | 2022-06-10 | 2022-06-10 | A composition for inhibiting Staphylococcus aureus biofilm and its preparation method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210649548.3A CN114931599B (en) | 2022-06-10 | 2022-06-10 | A composition for inhibiting Staphylococcus aureus biofilm and its preparation method |
Publications (2)
Publication Number | Publication Date |
---|---|
CN114931599A CN114931599A (en) | 2022-08-23 |
CN114931599B true CN114931599B (en) | 2023-07-14 |
Family
ID=82866900
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210649548.3A Active CN114931599B (en) | 2022-06-10 | 2022-06-10 | A composition for inhibiting Staphylococcus aureus biofilm and its preparation method |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114931599B (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107712199A (en) * | 2017-11-13 | 2018-02-23 | 赵露曦 | A kind of beauty treatment scented tea and preparation method thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9056083B2 (en) * | 2005-05-24 | 2015-06-16 | Pom Wonderful, Llc | Pomegranate fruit polyphenol composition and methods of use and manufacture thereof |
US7897184B1 (en) * | 2009-08-13 | 2011-03-01 | Access Business Group International Llc | Topical composition with skin lightening effect |
-
2022
- 2022-06-10 CN CN202210649548.3A patent/CN114931599B/en active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107712199A (en) * | 2017-11-13 | 2018-02-23 | 赵露曦 | A kind of beauty treatment scented tea and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
CN114931599A (en) | 2022-08-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101637503A (en) | Broussonetia papyrifera leaf total flavone extract and preparation method and application thereof | |
CN102973608A (en) | Application of effective part of cockroach extract in preparing drug for inhibiting fungus growth | |
CN102793881B (en) | Traditional Chinese medicine gel for treating vaginitis as well as preparation method and application of traditional Chinese medicine gel | |
WO2011035734A1 (en) | Relinqing extract, preparative method and use thereof | |
CN112316017A (en) | Gynecological antibacterial gel and preparation method thereof | |
CN104642399B (en) | The purposes of southern biennial wormwood extract preventing and treating notoginseng root rot | |
CN110585383A (en) | Antifungal compound extract, preparation and preparation method thereof | |
CN101422481A (en) | Use of Eupatorium adenophorum polysaccharide for antibiosis or antivirus | |
Ghamba et al. | In vitro antibacterial activity of crude ethanol, acetone and aqueous Garcinia kola seed extracts on selected clinical isolates | |
CN102283257A (en) | Application of elephantopus tomentosus in preventing and treating tobacco bacterial wilt | |
CN104642398B (en) | The purposes of southern biennial wormwood extract preventing and treating Alternaria panax | |
CN103848843B (en) | Extraction method of active components of Artemisia annua and application of the components in resisting plant diseases | |
CN113402626A (en) | Nymphaea hybrid polysaccharide extract and preparation method and application thereof | |
CN114931599B (en) | A composition for inhibiting Staphylococcus aureus biofilm and its preparation method | |
CN106344663A (en) | Preparation method of Jin Ying Huang Gui injection | |
CN105963334A (en) | Great burdock fruit extract and preparation method thereof and application of great burdock fruit extract in bacteriostasis | |
CN106038398A (en) | Method for preparing cortex phellodendri extract and application of cortex phellodendri extract composition prepared from cortex phellodendri extract in bacteriostatic agent | |
CN104642400A (en) | Application of artemisia verlotorum extract to prevention and control of panax pseudoginseng anthracnose | |
CN100571721C (en) | Long stalk Fructus Schisandrae Sphenantherae extract, Preparation Method And The Use | |
Xu et al. | Application of Atractylodes Macrocephala Koidz Extract in Methicillin-Resistant Staphylococcus Aureus | |
CN114306164A (en) | Antibacterial acne-removing cream and preparation method thereof | |
CN110251499A (en) | Dandelion extract and its use in preparing medicine for preventing and treating women's vaginal diseases | |
CN106511420B (en) | New use of radix Cynanchi Atrati as antifungal agent | |
CN105213871A (en) | A kind of emergency department bactericidal haemostatic Chinese medicine preparation | |
CN105287734A (en) | Traditional Chinese medicinal paper with antibacterial effect and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |